Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03712904
Title Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

uveal melanoma

Therapies

Aflibercept

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.